5 Best-Performing Stocks in the Last 12 Months

2. Cabaletta Bio, Inc. (NASDAQ:CABA)

Share Price Gains Over the Past 12 Months Through August 11: 746%

Clinical-stage biotechnology company Cabaletta Bio, Inc. (NASDAQ:CABA) works on T-cell therapies for patients with B cell-mediated autoimmune diseases.

Cabaletta Bio, Inc. (NASDAQ:CABA) has gained about 746% over the past 12 months. As of the end of the first quarter of 2023, 17 hedge funds tracked by Insider Monkey were long Cabaletta Bio, Inc. (NASDAQ:CABA). The biggest stakeholder of Cabaletta Bio, Inc. (NASDAQ:CABA) during this period was Phill Gross and Robert Atchinson’s Adage Capital Management with a $21 million stake in the company.